CBUS Cibus, Inc.
Price Chart
Executive Summary
Cibus, Inc. (CBUS) is conducting a public offering of 6,976,744 shares of Class A common stock at $2.15 per share, raising approximately $13.5 million in net proceeds. The funds will be used for working capital and to advance its herbicide tolerance traits in rice. The offering comes amid substantial doubt about the company's ability to continue as a going concern due to a cash balance of $9.9 million and current liabilities of $16.9 million as of December 31, 2025.
Actionable Insight
Traders should monitor Cibus's cash runway and progress in securing additional financing, as the current offering may only provide temporary relief. The significant dilution and going concern warning suggest continued financial stress, which could pressure the stock price despite the capital raise.
Key Facts
- Cibus is offering 6,976,744 shares at $2.15 per share, with an option for the underwriter to purchase up to 1,046,511 additional shares.
- Net proceeds are estimated at $13.5 million (or $16.0 million if the option is fully exercised), to be used for working capital and development of rice herbicide tolerance traits.
- As of December 31, 2025, Cibus had $9.9 million in cash and $16.9 million in current liabilities, raising substantial doubt about its ability to continue as a going concern.
- The offering price of $2.15 is below the last reported sale price of $2.71 on March 24, 2026, indicating a 20.7% discount.
- New investors will experience immediate dilution of $5.88 per share, as the adjusted net tangible book value per share is $(3.73) after the offering.
Financial Impact
Raises $13.5 million in net proceeds, increasing shares outstanding by approximately 12.8% (from 54.4 million to 61.4 million).
Risk Factors
- Substantial doubt about the company's ability to continue as a going concern due to insufficient cash to cover liabilities.
- Significant immediate dilution of $5.88 per share for new investors.
- Potential for further equity dilution from future offerings, including a planned $50 million at-the-market program.
Market Snapshot
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 424B5 Filing (Primary) | 0001193125-26-126646 |
| Document: d110894dexfilingfees.htm | 0001193125-26-126646 |
| Document: 0001193125-26-126646-index-headers.html | 0001193125-26-126646 |
| Document: 0001193125-26-126646-index.html | 0001193125-26-126646 |
| Document: 0001193125-26-126646.txt | 0001193125-26-126646 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 11, 2026
4d ago
|
Institutional Cluster
| $1.21 awaiting T+5 | awaiting T+5 | — | $1.23 (+2.07%) |
|
Jun 9, 2026
5d ago
|
8-K
| $1.22 awaiting T+5 | awaiting T+5 | — | $1.23 (+1.23%) |
|
Jun 8, 2026
6d ago
|
Press Release
| $1.22 awaiting T+5 | awaiting T+5 | — | $1.23 (+1.23%) |
|
May 26, 2026
20d ago
|
EFFECT
| $1.43 $1.39 | ▲ +2.80% | ▲ +4.01% | $1.23 (+13.99%) |
|
May 14, 2026
4w ago
|
8-K
| $1.31 $1.38 | ▲ +5.34% | ▲ +4.38% | $1.23 (−6.11%) |
|
May 4, 2026
5w ago
|
Press Release
| $1.49 $1.38 | ▼ −7.38% | ▼ −10.32% | $1.23 (−17.45%) |
|
Apr 20, 2026
7w ago
|
DEFA14A
| $1.49 $1.42 | ▼ −4.70% | ▼ −5.78% | $1.23 (−17.45%) |
|
Mar 26, 2026
11w ago
|
424B5
| $1.88 $1.91 | ▼ −1.60% | ▲ +2.27% | $1.23 (+34.57%) |
|
Mar 26, 2026
11w ago
|
Press Release
| $2.13 $1.98 | ▼ −7.04% | ▼ −8.68% | $1.23 (−42.25%) |
|
Mar 25, 2026
11w ago
|
Press Release
| $2.13 $1.98 | ▼ −7.04% | ▼ −8.68% | $1.23 (−42.25%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access